These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11361589)
1. Preclinical data on the antiretroviral activity of AZT. Laurence J AIDS Patient Care STDS; 1996 Aug; 10(4):208-9. PubMed ID: 11361589 [No Abstract] [Full Text] [Related]
2. AIDS research. FDA panel recommends anti-HIV drug for prevention. Cohen J Science; 2012 May; 336(6083):792. PubMed ID: 22605725 [No Abstract] [Full Text] [Related]
3. FDA approves first drug to prevent HIV infection. Roehr B BMJ; 2012 Jul; 345():e4879. PubMed ID: 22807165 [No Abstract] [Full Text] [Related]
4. Public health. Regulatory challenges in microbicide development. Coplan PM; Mitchnick M; Rosenberg ZF Science; 2004 Jun; 304(5679):1911-2. PubMed ID: 15218130 [No Abstract] [Full Text] [Related]
6. 100th HIV/AIDS antiretroviral drug approved by PEPFAR. AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372 [No Abstract] [Full Text] [Related]
7. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults. Blackwell CW Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852 [TBL] [Abstract][Full Text] [Related]
8. FDA grants tentative approval to first generic version of antiretroviral Viread. AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039 [No Abstract] [Full Text] [Related]
9. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp. Kessler H Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429 [No Abstract] [Full Text] [Related]
10. Abacavir (Ziagen) approval recommended. AIDS Treat News; 1998 Nov; (No 306):4. PubMed ID: 11365961 [TBL] [Abstract][Full Text] [Related]
11. New developments in antiretroviral treatment. Sadovsky R Am Fam Physician; 1999 Dec; 60(9):2663, 2666. PubMed ID: 10605997 [No Abstract] [Full Text] [Related]
12. FDA notifications. Reyataz is approved for HIV treatment. AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309 [TBL] [Abstract][Full Text] [Related]
13. Abacavir gets green light from FDA advisory board. Food and Drug Administration. TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365924 [TBL] [Abstract][Full Text] [Related]
14. FDA approval of nevirapine for HIV. Am Fam Physician; 1996 Oct; 54(5):1805-6. PubMed ID: 8857799 [No Abstract] [Full Text] [Related]
15. Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets. Adamson CS; Freed EO Mol Interv; 2009 Apr; 9(2):70-4. PubMed ID: 19401538 [TBL] [Abstract][Full Text] [Related]
16. National AIDS conference focuses on front lines of prevention, treatment. AIDS Policy Law; 2003 Apr; 18(7):1, 4. PubMed ID: 12728843 [No Abstract] [Full Text] [Related]
17. FDA notifications. Tentative approval granted for combo antiretroviral drug. AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009 [No Abstract] [Full Text] [Related]
18. First of a kind in HIV treatment. FDA Consum; 2006; 40(6):34. PubMed ID: 17333565 [TBL] [Abstract][Full Text] [Related]
19. Is it time to rethink the expanded-access programs for HIV infection? Amorosa V; Tebas P J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316 [TBL] [Abstract][Full Text] [Related]
20. I'm still the optimist. Burgess G Surviv News (Atlanta Ga); 2001 Dec; ():17. PubMed ID: 11802621 [No Abstract] [Full Text] [Related] [Next] [New Search]